Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pulmatrix Inc
PULMCurrent price
7.16 USD
-0.31 USD (-4.15%)
Last closed
7.47 USD
Company
www.pulmatrix.com
ISIN
US74584P3010
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
22 059 772 USD
Yield for 12 month
+328.74 %
1Y
3Y
5Y
10Y
15Y
PULM
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts. Address: 36 Crosby Drive, Bedford, MA, United States, 01730
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.00 USDP/E ratio
–Dividend Yield
–Current Year
+7 298 000 USD
Last Year
+6 071 000 USD
Current Quarter
+366 000 USD
Last Quarter
+1 552 000 USD
Current Year
-8 220 000 USD
Last Year
+6 071 000 USD
Current Quarter
+366 000 USD
Last Quarter
+1 391 000 USD
Key Figures PULM
1 year
3 years
5 years
10 years
EBITDA
-11 142 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-29.99 %
PEG Ratio
–
Return On Equity TTM
-58.99 %
Wall Street Target Price
10.00 USD
Revenue TTM
11 392 000 USD
Book Value
4.93 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-15.80 %
Dividend Yield
–
Gross Profit TTM
6 071 000 USD
Earnings per share
-2.64 USD
Diluted Eps TTM
-2.64 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-95.18 %
Dividend Analytics PULM
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History PULM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
01.03.2022
Stock Valuation PULM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.13
Price Sales TTM
1.94
Enterprise Value EBITDA
1.57
Price Book MRQ
2.02
Financials PULM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PULM
For 52 weeks
1.55 USD
8.44 USD
50 Day MA
3.78 USD
Shares Short Prior Month
411 614
200 Day MA
2.43 USD
Short Ratio
0.75
Shares Short
58 595
Short Percent
0.19 %
BeatStart